UNSPSC 41131710: Fibrinogen/fibrin degradation products assay

In this classification a fibrinogen/fibrin degradation products assay is a device used to detect and measure fibrinogen degradation products and fibrin degradation products (protein fragments produced by the enzymatic action of plasmin on fibrinogen and fibrin) as an aid in detecting the presence and degree of intravascular coagulation and fibrinolysis (the dissolution of the fibrin in a blood clot) and in monitoring therapy for disseminated intravascular coagulation (non localized clotting in the blood vessels) US FDA regulates Fibrinogen/fibrin degradation products assay under 21 CFR 864.7320 and under FDA product code MIF.

UNSPSC 41131710 Fibrinogen/fibrin degradation products assay is a Commodity code that does not align with the recent state and local contract opportunities posted under this classification. The source shows no recent solicitations for fibrinogen or fibrin degradation product testing kits, reagents, controls, or related laboratory supplies. Instead, the opportunities tagged to this code reflect a mismatch: they include offender drug testing services (Collin County, Texas), naloxone procurement and drug deactivation systems (Seminole County, Florida), urinalysis testing for a family treatment court (Benton County, Oregon), clozapine assay kits for psychiatric monitoring (State of Oregon), forensic drug standards for seized-drug analysis (Pinellas County, Florida), employment physicals and drug testing (Collier County and Clay County, Florida), employment screening services including drug testing (City Colleges of Chicago), and breath alcohol testing equipment (Nevada Department of Public Safety). These opportunities span drug testing services delivery, alternative specimen testing (oral fluid, hair), and alcohol testing equipment—none of which fall within the fibrinogen/fibrin degradation assay scope.

The code shows minimal decision-relevant recent activity for its actual commodity class. State and local procurement under UNSPSC 41131710 does not appear to be generating current solicitation volume; the opportunities in the source are substantially unrelated to coagulation or fibrinolysis marker testing. Vendors pursuing fibrinogen assay products or services should monitor alternative UNSPSC codes more closely aligned with clinical laboratory testing consumables, hematology analyzers, or point-of-care testing supplies, as the recent activity here does not support business development targeting under this code.